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Abstract. 
 
p21-activated kinases (Paks) are effectors of
the small GTPases Cdc42 and Rac, and are thought to
mediate some of the cytoskeletal and transcriptional
activities of these proteins. To localize activated Pak1
in cells, we developed an antibody directed against a
phosphopeptide that is contained within the activation
loop of Pak1. This antibody speciﬁcally recognizes the
activated form of Pak1. Immunoﬂuorescence analysis
of NIH-3T3 cells coexpressing activated Cdc42 or Rac1
plus wild-type Pak1 shows that activated Pak1 accumu-
lates at sites of focal adhesion, throughout ﬁlopodia
and within the body and edges of lamellipodia. Plate-
let-derived growth factor stimulation of NIH-3T3 cells
shows a pattern of Pak1 activation similar to that ob-
served with Rac1. During closure of a ﬁbroblast mono-
layer wound, Pak1 is rapidly activated and localizes to
the leading edge of motile cells, then gradually tapers
off as the wound closes. The activation of Pak1 by
wounding is blocked by inhibitors of phosphatidylino-
sitol 3-kinase, and Src family kinases, but not by an in-
hibitor of the epidermal growth factor receptor. These
ﬁndings indicate that activated Pak1, and by extension,
probably activated Cdc42 or Rac, accumulates at sites
of cortical actin remodeling in motile ﬁbroblasts.
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Introduction
 
Cell motility is a complex and dynamic process. Portions of
the molecular mechanisms that link extracellular stimuli to
the remodeling of actin and to changes in cell motility have
recently come into view. Small GTPases of the Rho family,
 
such as Cdc42, Rac, and Rho, are key regulators of actin
assembly and control the formation of filopodia, lamellipo-
dia, and stress fibers, respectively (Hall, 1998). The proxi-
mal means by which Cdc42, Rac, and Rho small GTPases
regulate actin dynamics and cell motility are presumably
related to the suite of effector proteins recruited by these
GTPases. Among these effectors, the p21-activated protein
 
kinases (Paks)
 
1
 
 have come under particular scrutiny due to
a growing body of genetic and biochemical data implicating
Paks in regulating the structure of the actin cytoskeleton.
 
Paks are a highly conserved group of enzymes that act as
effectors for the Rho family GTPases Cdc42 and Rac (Lim
et al., 1996; Sells and Chernoff, 1997; Bagrodia and Cerione,
1999; Daniels and Bokoch, 1999). Paks specifically associate
with the activated (GTP-bound) forms of Cdc42 and Rac
and are thought to mediate some of their effects on actin or-
ganization, motility, adhesion, and gene transcription. Upon
binding to these GTPases, Pak undergoes a conformational
change, accompanied by autophosphorylation at several
sites and a marked increase in kinase activity towards ex-
 
ogenous substrates. In mammalian cells, these substrates in-
clude LIM kinase (Edwards et al., 1999), myosin light chain
kinase (Sanders et al., 1999), Bad (Schurmann et al., 2000),
Raf (King et al., 1998), and Mek (Frost et al., 1997), and un-
doubtedly other proteins that remain to be discovered.
 
In resting cells, Pak1 is localized to membranous struc-
tures within the cytoplasm (Dharmawardhane et al., 1997).
Upon stimulation of cells by growth factors, Pak is re-
cruited to focal adhesions and sites of membrane ruffles,
although the activity of Pak in any of these locations is not
known (Dharmawardhane et al., 1997; Manser et al.,
1997). As Pak1 itself lacks a focal adhesion targeting mo-
tif, it is likely that Pak1 is brought to these locations by its
binding partners. These proteins include the guanine nu-
cleotide exchange factor PIX (Manser et al., 1998), which
 
binds to a linker protein known as p95
 
Pkl
 
 that in turn binds
to the focal adhesion protein paxillin (Turner et al., 1999).
In addition, Pak1 may be brought to the plasma mem-
brane and to focal adhesion complexes via its association
with the adaptor protein Nck (Bagrodia et al., 1995;
Bokoch et al., 1996; Galisteo et al., 1996; Hing et al., 1999),
which binds to activated receptor tyrosine kinases as well
as to tyrosine phosphorylated focal adhesion proteins such
as Fak, p130
 
Cas
 
, and HEF1 (Minegishi et al., 1996; Law et
al., 1996; Schlaepfer et al., 1997; Tu et al., 1999).
 
We have developed an antibody that reacts specifically
with an autophosphorylated, activated form of Pak1, and
here report the use of this reagent to reveal the spatial and
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temporal distribution of activated Pak1 in cells. We show that
activated Pak1 accumulates at focal adhesions, throughout
filopodia, and in the body and edges of lamellipodia. Further,
we are able to document the dynamic behavior of Pak1 acti-
vation during cell movement after wounding of a confluent fi-
broblast monolayer, and to dissect the signaling elements that
mediate Pak1 activation by wound healing.
 
Materials and Methods
 
Materials
 
Polyclonal antibodies against Pak1 (C19) were obtained from Santa Cruz
Biotechnology, Inc. Monoclonal antibodies against Myc (9E10) and he-
magglutinin (HA; 12CA5) were from Santa Cruz Biotechnology, Inc. and
BabCo, respectively, antipaxillin was from Transduction Laboratories, and
LY294002, tyrphostin AG1478, and PP1 were obtained from Calbiochem.
 
Phospho-specific Antibodies
 
The phosphopeptide SKRST(P)MVGTPYC, derived from amino acid
residues 419–429 in human Pak1 (Sells et al., 1997), was synthesized and
coupled to keyhole limpet hemocyanin via a COOH-terminal linkage. The
coupled peptide was injected into rabbits and the resulting antisera puri-
fied by protein A–Sepharose chromatography. The sera were then affinity
purified, first by passage over a nonphosphorylated peptide (EQSKRST-
MVGTPYWMAPEVVTRK) column to remove antibodies that react
with nonphosphorylated epitopes, then by passage over a phosphopeptide
column. The sera were eluted in 1-ml fractions from this column with 0.1
M glycine, pH 2.5, immediately neutralized by the addition of 50 
 
m
 
l 1 M
Tris, pH 9.5, then extensively dialyzed against PBS.
 
Protein Production
 
His-tagged, activated (L107F) and inactive (K299A) human Pak1 (a gift
from P. Diamond, Harvard University, Cambridge, MA) were produced
via baculovirus infection of Sf9 cells and purified by metal chelate chro-
matography. The purified proteins were dialyzed against PBS and stored
at a concentration of 1 mg/ml in 10-
 
m
 
l aliquots at 
 
2
 
80
 
8
 
C. Mst2 was simi-
larly produced, but not purified, from a baculovirus-infected Sf9 cell lysate
(a gift from A. Abo, Onyx Pharmaceuticals, Richmond, CA).
 
Cell Culture
 
NIH-3T3 S2-6 cells (Shockett et al., 1995) expressing wild-type or mutant
forms of Pak1 under a tetracycline-regulated promoter were maintained in
DME plus 10% calf serum, 2.5 mM histidinol, 2 
 
m
 
g/ml puromycin, and 1
mg/ml tetracycline (Sells et al., 1999). COS1 cells were grown in DME,
10% fetal bovine serum containing 50 U/ml penicillin, 50 
 
m
 
g/ml streptomy-
cin, 100 
 
m
 
g/ml kanamycin. Where indicated, cells were transfected using li-
pofectamine (GIBCO BRL) according to the manufacturer’s protocol.
 
PDGF Stimulation
 
NIH-3T3 S2-6 cells (Shockett et al., 1995) expressing wild-type Pak1 under a
tetracycline-regulated promoter were induced for Pak1 expression, starved
in 0.2% calf serum for 16 h, and then stimulated with 30 ng/ml PDGF for 5
or 10 min. The cells were then fixed and stained as indicated below.
 
Immunoblot
 
Cells were lysed in NP-40 lysis buffer (50 mM Tris-HCl, pH 8.0, 137 mM
NaCl, 10% glycerol, 1% NP-40, 50 mM NaF, 10 mM 
 
b
 
-glycerol-phos-
phate) containing 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl
fluoride, and 10 
 
m
 
g per ml aprotinin. 10 
 
m
 
g extract was fractionated by
10% SDS-PAGE and transferred to polyvinyl difluoride (Immobilon)
membranes. Membranes were blocked using fat-free milk, probed with
antibodies, and developed using an alkaline phosphatase–based chemilu-
minescence system (Dupont/New England Nuclear).
 
Protein Kinase Assays
 
0.5 
 
m
 
g recombinant Pak1 or Mst2, purified from baculovirus-infected Sf9
cells, was incubated in 25 
 
m
 
l protein kinase buffer (50 mM Tris-HCl, pH
7.5, 10 mM MgCl
 
2
 
, 1 mM DTT) containing 25 
 
m
 
M ATP plus 5 
 
m
 
Ci
 
[
 
g
 
-
 
32
 
P]ATP at 30
 
8
 
C for 20 min. The reactions were stopped by the addi-
tion of 5 
 
m
 
l 6
 
3
 
 SDS-PAGE sample buffer, boiled for 5 min, then sepa-
rated by 10% SDS-PAGE. The dried gel was then autoradiographed.
 
Immunofluorescence Detection
 
Cells cultured on coverslips were fixed in 3.5% formaldehyde, permeabi-
lized in 0.1% Tween 20, and blocked with 3% BSA in PBS. After incuba-
tion with primary antibodies, the cells were stained with Rhodamine
X–conjugated goat anti–rabbit antibodies along with AMCA-conjugated
and Cy5-conjugated goat anti–mouse antibodies. For staining of F-actin,
0.05 
 
m
 
M Oregon green–conjugated phalloidin was included along with sec-
ondary antibodies. Confocal microscopy was performed using a Bio-Rad
Laboratories MRC 600 laser scanning confocal microscope. Other photomi-
crographs were obtained using a Quantix CCD and the Isee™
 
 
 
imaging pro-
gram from Inovision. This same system was used for gray scale quantitation.
 
Cell Wounding Assays
 
Marginally subconfluent cells were induced for 36 h and starved for 24 h in
DME plus 0.5% calf serum. After these treatments, the confluent mono-
layer of cells was wounded by scraping a narrow 200 
 
m
 
l Rainin Pipetman
tip across a 100-mm plate 4 times (in experiments where cells were plated
onto coverslips) or 60 times (for cells plated onto 100-mm plates for Pak1
autophosphorylation assay). For inhibitor studies, LY294002 (25 
 
m
 
M),
PP1 (10 
 
m
 
M), or tyrphostin AG1478 (10 
 
m
 
M) was added 10 min before
wounding. For activity assays, cells were lysed at appropriate times there-
after in NP-40 lysis buffer and assayed for the presence of autophosphory-
lated Pak1 by immunoblot.
 
Results
 
Production and Specificity of Phospho-specific 
Anti-Pak Sera
 
Upon activation by Cdc42, Rac, or sphingolipids, Pak1 is
known to autophosphorylate at several sites, including
threonine 423 within the activation loop of the kinase
(Manser et al., 1997; Zenke et al., 1999). Phosphorylation
at threonine 423 is strongly correlated with activation, and
substitution of the acidic residue glutamic acid at this site
yields a constitutively active enzyme (Manser et al., 1997;
Sells et al., 1997). To create a reagent that could be used to
identify only activated Pak, we raised antibodies against a
phosphorylated peptide that encompassed the activation
loop of human Pak1 (Fig. 1 A).
To demonstrate the specificity of this reagent, we incu-
bated purified constitutive-active (CA) or inactive, kinase-
dead (KD) Pak1 in protein kinase buffer in the presence
of ATP, then performed immunoblots using anti-Pak1 and
antiphospho-Pak, as well as autoradiography to detect
phosphorylated proteins (Fig. 1 B). While both forms of
the protein were detected with anti-Pak1, only activated
Pak1 was detected using the phospho-specific antibody,
despite the large amount of recombinant protein used in
this assay. Similar results were obtained when purified
wild-type Pak1 was activated
 
 
 
in vitro with GTP-Cdc42
(Fig. 1 C). These results show that the phospho-Pak anti-
sera recognize active, autophosphorylated Pakl, but are not
able to recognize inactive, nonautophosphorylated Pak1.
The sensitivity of the phospho-Pak sera in immunoblots
compares favorably with a widely used commercial anti-
Pak1 reagent. Decreasing amounts of phosphorylated ac-
tive and nonphosphorylated inactive Pak1 were probed
with both anti-Pak1 and antiphospho-Pak. The results
show that antiphospho-Pak detects as little as 20 ng of acti-
vated Pak1 protein in immunoblots (Fig. 1 D).
Because members of the Pak and germinal center (GC)
kinase family share a nearly identical activation loop se- 
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quence (Fig. 2 A), we asked whether the phospho-Pak sera
might cross-react with activated forms of these kinases
(Fig. 2 B). Autophosphorylated Mst2 (a member of the GC
kinase group) (Creasy and Chernoff, 1995; Sells and Cher-
noff, 1997) was recognized by the antiphospho-Pak sera,
demonstrating that this antibody is not absolutely specific
for Pak1. As expected, these sera also cross-reacted with
Pak2, which has an identical activation loop, but not with
protein kinase D–activated Akt, which bears a similar, but
not identical sequence at this site (data not shown).
 
Antiphospho-Pak Sera Detects Activated Pak1 in
Cell Lysates
 
We next asked if the antiphospho-Pak sera could be used to
detect activated Pak1 in cell lysates. COS cells were cotrans-
fected with Myc-tagged Pak1 plus HA-tagged wild-type or
activated Cdc42, activated Rac1, or activated RhoA, and ly-
sates were probed by immunoblot with anti-Myc (to detect
exogenous Pak1), antiphospho-Pak, and anti-HA (to detect
the GTPases) (Fig. 3, A and B). In cells expressing Myc-
tagged Pak1 but lacking activated exogenous GTPases,
faint bands of 
 
z
 
47 and 53 kD are detected upon blotting
with antiphospho-Pak (Fig. 3 A, lanes 1, 3, and 5). The in-
tensity of these bands does not change upon coexpression of
activated GTPases (lanes 2, 4, and 6), nor is the intensity de-
 
creased in cells not expressing exogenous Pak1 (not shown),
indicating that they are unlikely to represent Paks. The an-
tiphospho-Pak blot clearly detects an 
 
z
 
70-kD band in cells
transfected with activated (L61) forms of Cdc42 (Fig. 3 A,
lane 2) and Rac1 (Fig. 3 A, lane 4), but not with an activated
(L63) form of RhoA (Fig. 3 A, lane 6). Anti-Myc blots re-
veal upshifted bands in the same lanes, consistent with auto-
phosphorylation of Pak1. These data are consistent with the
known properties of Pak1: it binds to, and is activated by,
Cdc42 and Rac but not RhoA (Manser et al., 1994). In cells
transfected with activated Cdc42, but not Myc-tagged Pak1,
only the background 47- and 53-kD signals are seen with an-
tiphospho-Pak (data not shown). The amount of 
 
z
 
70-kD
band detected by the antiphospho-Pak in lysates from COS
cells cotransfected with Pak1 plus wild-type Cdc42 (Fig. 3 B,
lane 1) is dramatically less than that detected from cells
cotransfected with Pak1 and activated Cdc42 (Fig. 3 B, lane
2), consistent with the well-established fact that Cdc42 must
be activated in order to activate Pak1.
These results show that antiphospho-Pak can recognize
exogenous activated Pak1 in cell lysates. Although the an-
tiphospho-Pak antibody is not completely specific for acti-
vated Pak1, our results also show that, under basal condi-
tions, endogenous Pak1, as well as other Paks, is either
inactive or not present in sufficient quantity in cell lysates to
be recognized by these sera. The 47- and 53-kD proteins de-
tected by the phospho-Pak sera might represent members
of the related GC kinase family. However, these signals do
not change in response to GTPase expression (Fig. 3 A) or
other stimuli that we tested, such as growth factor stimula-
tion or monolayer wounding (see below). Therefore, in ly-
sates from transfected COS cells, positive signals can be
attributed to the transgenic Pak1 rather than to other en-
dogenous protein kinases in the Pak/GC kinase family.
 
Cotransfection of Wild-Type Pak1 and Activated Cdc42 
or Rac Stimulates Pak1 Phosphorylation in Cortical 
Actin-based Structures
 
We have previously developed tetracycline-regulated
NIH-3T3 cells lines that inducibly express Pak1 (Sells et
Figure 1. Antiphospho-Pak1 antibody specifically recognizes acti-
vated Pak1. (A) Activation loop sequence of the phosphorylated
peptide used for production of polyclonal antiphospho-Pak1 anti-
sera. (B) Immunoblots (lanes 1–4) and radiolabeled kinase reac-
tion products (lanes 5 and 6) of baculovirus-produced Pak1. Puri-
fied KD or CA Pak1 was incubated in protein kinase buffer in the
presence of ATP, then immunoblotted using anti-Pak1 (lanes 1
and 2) and antiphospho-Pak antisera (lanes 3 and 4) autoradio-
graphed to detect antibody-bound proteins. Although both forms
of the protein were detected with anti-Pak1, only activated Pak1
was detected using the phospho-specific antibody, despite the
large amount of recombinant protein used in this assay. Lanes 5
and 6 show autoradiographed PAGE gel of reaction products
from a kinase assay performed in the presence of [g-32P]ATP.
Molecular mass in kilodaltons is shown to the right of the blot.
(C)  Comparison between immunoblot and radiolabeled kinase
reaction products of Pak1 activated by Cdc42. Purified baculovi-
rally produced Pak1 was incubated with or without activated
Cdc42, as indicated. The kinase was then incubated in protein ki-
nase buffer, containing histone 4 as substrate, in the presence of
[g-32P]ATP. An immunoblot and autoradiogram are shown. (D)
Sensitivity of antiphospho-Pak sera. 20–100 ng of KD and CA
Pak1 were probed with both anti-Pak1 and antiphospho-Pak.
Figure 2. Cross-reactivity with Pak-related kinases. (A) Compar-
ison of activation loop sequences in Pak1 and Mst2. (B) Purified,
autophosphorylated recombinant Pak1 and Mst2 were assayed
and probed as in the legend to Fig. 1. 
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al., 1999). These cells, as well as cells that inducibly ex-
press wild-type Pak1 plus activated Cdc42 or Rac1, were
used to determine the subcellular location of activated
Pak1. In control cells, little phospho-Pak1 is detected by
immunofluorescence, consistent with the low basal activity
of this enzyme (Fig. 4, A, D, and G). Cells coexpressing
Pak1 plus activated Rac1 develop extensive lamellipodia
and membrane ruffles, with activated Pak1 concentrated
 
primarily within the edges and body of these structures
(Fig. 4, B, E, and H). Similar experiments with cells ex-
pressing Pak1 plus activated Cdc42 develop microspikes
and filopodia, with phospho-Pak1 throughout the filopo-
dia (Fig. 4, C, F, and I). Pseudocoloration based on fluo-
rescence intensity of sagittal confocal images of these cells
defines the highest concentrations of phospho-Pak1 to be
in sites of dynamic cortical actin remodeling (Fig. 4, G–I).
 
PDGF Stimulates Pak1 Phosphorylation within 
Lamellipodia and Focal Adhesions
 
PDGF is known to activate Pak1 (Dharmawardhane et al.,
1997). Using the phospho-Pak antibody, we confirmed this
result in NIH-3T3 S2-6 cells expressing wild-type Pak1,
showing that maximal activation of an 
 
z
 
70-kD band,
comigrating with Myc-Pak1, occurs at 
 
z
 
5 min after treat-
ment (Fig. 5 A). No other PDGF-stimulated signals were
detected by the antiphospho-Pak sera (not shown). To as-
sess the distribution of activated Pak1 in response to
growth factors, we treated starved NIH-3T3 S2-6 cells ex-
pressing wild-type Pak1 with PDGF for 5 min, then deter-
mined the location of total and activated Pak1 by immu-
nofluorescence (Fig. 5 B). PDGF induces the formation of
lamellipodia. Whereas total Pak is expressed throughout
the cytoplasm (Fig. 5 B, panels c and g), the highest levels
of activated Pak1 (Fig. 5 B, panel f) are found within
lamellipodia. These data indicate that PDGF induces acti-
vation of a fraction of the total Pak1 pool, and that acti-
Figure 3. Antiphospho-Pak
sera detects activated Pak1 in
cell lysates. (A) COS1 cells
were transfected with wild-
type Pak1 alone (lanes 1, 3,
and 5), or wild-type Pak1 plus
activated Cdc42 (lane 2),
Rac1 (lane 4), or RhoA (lane
6). Lysates were probed with
anti-Myc (to detect exoge-
nous Pak1), antiphospho-Pak,
and anti-HA (to detect the
GTPases).  (B) COS1 cells
were cotransfected with wild-
type Pak1 in combination
with wild-type (WT) (lane 1)
or activated (L61) Cdc42
(lane 2). An immunoblot of
cell lysates was probed with
antiphospho-Pak.
Figure 4. Localization of GTPase-activated Pak1 in fibroblasts. Tetracycline-regulated NIH-3T3 cell lines that inducibly express Pak1
(A, D, and G), as well as cells that inducibly express wild-type Pak1 plus activated Rac1 (B, E, and H) or activated Cdc42 (C, F, and I),
were used to determine the subcellular location of activated Pak1. (A–C) Antiphospho-Pak1 staining (red); (D–F) merged phalloidin
(green) and antiphospho-Pak1 (red) and GTPase (blue). Colocalization of phospho-Pak1 and Cdc42 or Rac1 produces white-yellow;
(G–I) pseudocolored sagittal scans of these Z scanned images. Red, high intensity fluorescence; yellow, medium intensity fluorescence;
and blue, low intensity fluorescence. Bars, 25 mm. 
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vated Pak1 accumulates preferentially in growth factor–
induced, actin-based structures.
To quantitate these changes, we assessed the staining in-
tensity of total Pak1 and phospho-Pak in 20–30 control or
PDGF-treated cells. For Pak1, the staining intensity was un-
changed by PDGF treatment (mean average gray scale
pixel intensity 2,184.4 
 
6
 
 135.5 (arbitrary units) before
PDGF treatment, and 2,127.1 
 
6
 
 192.7 5 min after PDGF
treatment), whereas phospho-Pak1 levels increased by 28%
(735.1 
 
6
 
 24.9 to 942.9 
 
6
 
 63.6). For these measurements,
staining intensity across the entire cell was surveyed, rather
than just areas of membrane ruffles, and localized increases
in phospho-Pak staining are in fact much higher than 28%.
 
Pak1 Is Activated upon Fibroblast Monolayer 
Wounding and Localizes to the Leading Edge of 
Wounded Fibroblasts
 
To assess Pak1 activation kinetics in a cell culture system,
we wounded confluent monolayers of NIH-3T3 S2-6 cells
expressing wild-type Pak1 by scraping away a 200–250-
 
m
 
m
row of cells, then stained for phospho-Pak at defined time
intervals (Fig. 6). Before wounding, cells contained little
active Pak1. 5 min after wounding, cells expressing wild-
type Pak1 contained markedly more phospho-Pak1, par-
ticularly in cells near the wound edge (Fig. 6 A). Maximal
increase in activity (
 
z
 
2.5 fold) is seen by 15 min, followed
by a gradual decline (Fig. 6 B). The activation of Pak1 oc-
curs not only in the cells immediately lining the wound,
but also appears to extend back from the wound edge at
least several cell layers. Similar data have been reported
for the activation of extracellular signal–regulated kinase
(Erk) by monolayer wounding (Nobes and Hall, 1999). At
the wound edge, activated Pak1 colocalized with F-actin
(not shown). These data show that Pak1 is rapidly and spe-
cifically activated by monolayer wounding, accumulating
at localized sites of dynamic actin remodelling.
 
In cells closest to the wound edge, activated Pak1 accu-
mulates in leading edge lamellipodia that extend into the
wounded region (Fig. 7 A). A substantial portion of the
activated fraction of Pak1 also colocalizes with paxillin, a
marker of focal adhesions (Fig. 7, B and D). Thus, in a
wounded monolayer model, Pak1 is activated in cells
flanking the wound edge and accumulates in actin-based
structures that extend into the wounded region.
 
Signaling Elements Required for Pak1 Activation
by Wounding
 
The mechanisms by which monolayer wounding initiates
changes in cell shape and motility are not understood.
 
 
 
To
determine the outlines of the signal transduction pathways
that mediate Pak1 activation by wounding, we examined
the effects of chemical inhibitors of the EGF receptor, Src
family kinases, and phosphatidylinositol 3-kinases (PI3 ki-
nases) on Pak stimulation during this process. The EGF
receptor pathway was specifically targeted because this re-
ceptor kinase is frequently transactivated by non-growth
factor extracellular stimuli or stresses (e.g., cell–matrix ad-
hesion, stimulation of G protein–coupled receptors, and
UV irradiation) (for review see Weiss et al., 1997). Src is
similarly activated by a wide variety of stimuli, and PI3 ki-
nases are known to activate various Rac- and Cdc42-spe-
cific guanine nucleotide exchange factors. Cells expressing
wild-type Pak1 were therefore incubated with vehicle
alone, tyrphostin AG1478 (an EGF receptor inhibitor),
PP1 (a Src family kinase inhibitor), or LY294002 (a PI3 ki-
nase inhibitor) 10 min before extensive wounding. Mono-
layers were then either lysed, analyzed, and quantitated by
immunoblot (Fig. 8) or stained with antiphospho-Pak1 15
min after wounding and the staining intensity of phospho-
Pak was quantified (not shown). These experiments show
that the Src inhibitor PP1 and the PI3 kinase inhibitor
LY294002 effectively block Pak1 activation by wounding.
Figure 5. Activation of Pak1 by PDGF. (A) A tetracycline-regulated NIH-3T3 cell line express-
ing wild-type Pak1 was treated with PDGF. At the indicated times, the cells were lysed and ana-
lyzed by immunoblot using antiphospho-Pak antisera. The blot is representative of results ob-
tained from three independent experiments. (B) The cells were treated for 5 min with vehicle
alone (A–D) or 30 ng/nl PDGF (E–H), then fixed and stained for actin (A and E), phospho-Pak
(B and F), and Pak1 (C and G). These confocal images were then merged (D and H). Bar, 25 mm. 
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In contrast, the EGF inhibitor, tyrphostin AG1478, does
not affect Pak phosphorylation induced by wounding.
When examined by phase–contrast and by immunofluo-
rescence (rhodamine-phalloidin) microscopy, we found
that both PP1 and LY294002 inhibited ruffling in cells at
the wound edge, whereas tyrphostin AG1478 did not have
this effect (data not shown). Thus, there is a concordance
between the effects of these drugs on Pak1 activity and
ruffling in wounded fibroblasts.
 
Discussion
 
We show here for the first time the location of activated
Pak1 in cells. It was previously determined that a portion
of Pak1 relocalizes from membranous cytoplasmic struc-
tures to focal adhesion sites upon stimulation with growth
factors, but the activity of Pak in either location could not
be assessed (Dharmawardhane et al., 1997; Manser et al.,
1997). Using our phospho-specific antibody, we are now
able to determine when and where Pak1 is activated by ex-
tracellular stimuli or by coexpression of constitutively acti-
vated GTPases. As Pakl stably binds to activated Rac1 and
Cdc42 (Manser et al., 1994), the sites of phospho-Pak1 ac-
cumulation may also indirectly reveal the location of the
activated forms of these GTPases in fibroblasts.
The site of Pak activation is presumed to be at the plasma
membrane and/or sites of focal adhesion. This assumption is
supported by the finding that Pak binds to several proteins
that are known to localize to these structures. For example,
Pak1 directly binds to the adaptor protein Nck, which may
shuttle Pak to activated receptor protein tyrosine kinases at
the plasma membrane or to focal adhesions (Minegishi et
al., 1996; Lu et al., 1997; Schlaepfer et al., 1997). In addition,
Pak, through a series of intermediary proteins, indirectly
binds to the focal adhesion protein paxillin (Turner et al.,
1999). Our results show that, in cells overexpressing acti-
vated Cdc42 or Rac1, activated Pak1 accumulates through-
out filopodia and at the edges and within the body of lamel-
lipodia, respectively. These locations coincide with sites of
active actin polymerization in fibroblasts, suggesting that
Pak1 plays a role in this process (Symons and Mitchison,
1991; Welch et al., 1997; Chan et al., 1998; Schafer et al.,
1998; Bailly et al., 1999; Chan et al., 2000).
We and others have previously shown that Pak1 affects
the organization of the actin cytoskeleton (Manser et al.,
1997; Sells et al., 1997; Frost et al., 1998; Obermeier et al.,
1998). Although the mechanisms by which Pak1 and other
members of this enzyme family regulate actin dynamics
are not fully known, a portion of these effects may be me-
diated by phosphorylation of LIM kinase, which inacti-
vates the actin depolymerizing protein cofilin by phosphor-
ylating it at an NH
 
2
 
-terminal serine residue (Edwards et
al., 1999). Pak1 also alters the phosphorylation state of the
regulatory myosin light chain (RMLC), indirectly, through
phosphorylation and inhibition of the myosin light chain
kinase (Sanders et al., 1999), and directly, by phosphoryla-
tion of serine 19 in the RMLC (Ramos et al., 1997; Chew
et al., 1998; Sells et al., 1999; Zeng et al., 2000). Both these
activities are more than likely relevant to Pak’s effects on
cell morphology and motility. Finally, Pak also directly in-
fluences activity of Raf and Mek, and thereby Erk, which
might contribute to changes in actin structure and cell mo-
tility through activation of RMLC (Klemke et al., 1997;
Cheresh et al., 1999; Nguyen et al., 1999).
Figure 6. Temporal sequence of Pak1 activation in wounded fibroblasts. (A) Confluent mono-
layers of wild-type Pak1 expressing NIH-3T3 S2-6 cells were wounded by scraping away a 200–
250-mm row of cells, then stained for phospho-Pak and F-actin at defined intervals (0–120 min)
(not shown). A marked increase in activated Pak1 is seen within 5 min of wounding. Activated
Pak1 is most concentrated in cells at the edges of the monolayer wounds. The highest intracel-
lular levels are within lamellipodia (arrowhead), filopodia (arrows), and focal adhesions. Im-
ages were captured using cooled CCD with Isee™ software. (B) Time course of Pak1 activa-
tion as assessed by immunoblot. The assay was repeated three times with similar results. (C)
Quantitation of phospho-Pak1 levels, as assessed by densitometric scanning of immunoblots.
At least four uninduced samples were scanned per time point. Standard error was calculated
for all samples. Bar, 200 mm. 
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Our data show that active Pak1 accumulates at the lead-
ing edge of motile fibroblasts. Consistent with the pro-
posed role of this kinase in cell movement, expression of
activated forms of Pak1 in fibroblasts increases the persis-
tence of movement, while expression of a kinase-defective
form of Pak1 is associated with increased nondirected,
random movement (Sells et al., 1999). In 
 
Dictyostelium
 
,
Chung and Firtel (1999) have recently shown that Pak-a is
activated by chemoattractants and is required for chemo-
taxis and for cytokinesis. As in mammalian fibroblasts,
loss of Pak function is associated with random pseudopod
extension, whereas increase of Pak function is associated
with suppression of lateral pseudopod extension and in-
creased persistence of movement. However, in contrast to
our results in mammalian cells, in 
 
Dictyostelium
 
, Pak-a
predominantly localizes to the posterior of polarized,
chemotaxing cells. It should be noted that localization of
activated, as opposed to total, Pak-a could not be assessed
in these experiments. It is possible that Pak-a is activated,
as in mammalian fibroblasts, at the leading edge of loco-
moting 
 
Dictyostelium
 
 cells, but that the amount of acti-
vated Pak-a is small compared with the total pool of this
enzyme. As the activation loop sequence in 
 
Dictyostelium
 
Pak-a is similar to that of mammalian Pak1, it might be
possible to address this question using the phospho-spe-
cific antibody described here.
We have shown that Pak1 is activated by wounding of a
confluent monolayer. The signaling mechanisms that in-
duce cell shape changes and movement after wounding are
poorly understood. It is thought that wounding induces lo-
calized release of growth factors and cytokines which then
act upon adjacent cells to induce changes in gene expres-
sion, actin reorganization, polarization, and motogenesis.
Unlike integrin engagement (Moro et al., 1998; Li et al.,
1999), activation of signaling by monolayer wounding does
not appear to involve the EGF receptor, as the potent
EGF receptor inhibitor, tyrphostin AG1478, did not affect
Pak1 activation by wounding. However, our results do
support a role for PI3 kinase and Src family kinases in this
signaling pathway, as both LY294002 and PP1 effectively
blocked Pak1 activation by wounding.
Nobes and Hall (1999) showed that the wounding re-
sponse in Swiss 3T3 cells is likely to involve the small GTP-
ases Ras, Cdc42, Rac, and Rho. Based on experiments using
dominant-negative proteins, these authors showed that
Cdc42 plays an important role in cell polarization and that
Rac is essential for movement during wound closure. Based
on our results and on these data, it is reasonable to assume
that wounding activates, at a minimum, a Src family kinase,
PI3 kinase, and Cdc42 and/or Rac. Activation of kinases of
the Src family has been reported in fibroblasts treated with
thrombin (a likely mediator of at least part of the wounding
response) (Chen et al., 1994; Vaingankar and Martins-
Green, 1998). Our results with the Src inhibitor PP1 are
consistent with these data, and suggest that a Src family ki-
nase lies upstream of Rac/Cdc42 in this response pathway.
The production of phosphatidylinositol 3, 4, 5-triphosphate
by PI3 kinase has been linked to activation of Rho guanine
nucleotide exchange factors such as Sos, Vav, and Tiam1
(Han et al., 1998; Nimnual et al., 1998; Sander et al., 1998),
and therefore presumably to Rac or Cdc42 and its effectors
such as Pak. It should be noted, however, that measure-
ments of Rac activity after monolayer wounding have not
been reported. The indirect data presented here support
this model of wound-initiated signaling, suggesting that
Cdc42, Rac, or both proteins are activated by this event,
and that activation takes place in areas of dynamic actin re-
organization. It should be possible to further dissect this
proposed signaling pathway by a combination of additional
pharmacological, biochemical, and genetic approaches.
Figure 7. Colocalization of activated Pak1 and paxillin at the
leading edge of motile fibroblasts.  A monolayer of  wild-type
Pak1 expressing NIH-3T3 S2-6 cells were wounded as in the leg-
end to Fig. 6. The leading edge of the wounded monolayer is de-
picted. Cells were stained with (A) antiphospho-Pak1 (red); (B)
antipaxillin (blue); and (C) phalloidin (green). A merged image
(D) is also shown. Bar, 25 mm.
Figure 8. Signaling pathways required for Pak1 activation by
wounding. Monolayers of wild-type  Pak1 expressing NIH-3T3
S2-6 cells were pretreated for 10 min with the indicated com-
pounds, then wounded as in the legend to Fig. 6. (A) 15 min after
wounding, the cells were lysed and immunoblotted with an-
tiphospho-Pak. All assays were carried out in triplicate. (B)
These data were also quantified by PhosphorImager (Fuji) analy-
sis. LY, LY294002; TP, tyrphostin AG1478. 
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Monolayer wounding has also been shown to stimulate
Erk activity (Nobes and Hall, 1999). As Pak has been impli-
cated in stimulating Erk in growth factor signaling transduc-
tion, through phosphorylation of Raf and Mek (Frost et al.,
1997; King et al., 1998), it is possible that Pak also is re-
quired for wound-initiated Erk activation. We are currently
testing this hypothesis by use of specific Pak inhibitors such
as the Pak inhibitory domain (Zhao et al., 1998).
This report defines, for the first time, the subcellular lo-
calization of activated Pak1. In response to extracellular
stimuli such as growth factor stimulation or wounding,
Pak1 phosphorylation, an indicator of enzymatic activa-
tion, can be detected by the antiphospho-Pak antibody de-
scribed herein. Irrespective of stimulus used, it appears
that the bulk of phospho-Pak accumulates in areas of cor-
tical actin polymerization. This pattern of activation sug-
gests a direct role for Pak1 in regulating actin dynamics at
these sites. The exact mechanism of Pak1’s role in actin re-
modeling, however, remains to be defined.
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